Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3766948 | 0.81 | ALDH1A1 (0.53) | ALDH1A1HPGDTSHRPOLBCYP2C19 | |
| SCHEMBL14718636 | 0.75 | MAPT (0.44) | ALDH1A1MAPTLMNASMN1; SMN2MEN1 | |
| SCHEMBL2397527 | 0.72 | ALDH1A1 (0.58) | ALDH1A1HPGDTSHRPOLBCYP2C19 | |
| SCHEMBL6856779 | 0.71 | ALDH1A1 (0.62) | ALDH1A1HPGDTSHRPOLBCYP2C19 | |
| SCHEMBL3503446 | 0.71 | ALDH1A1 (0.62) | ALDH1A1HPGDTSHRPOLBCYP2C19 | |
| SCHEMBL31481622 | 0.71 | ALDH1A1 (0.62) | ALDH1A1HPGDTSHRPOLBCYP2C19 | |
| SCHEMBL3325090 | 0.71 | ALDH1A1 (0.51) | ALDH1A1TSHRCYP1A2RAB9ANPC1 | |
| SCHEMBL19514727 | 0.71 | ALDH1A1 (0.56) | ALDH1A1HPGDTSHRPOLBCYP2C19 | |
| SCHEMBL5186243 | 0.70 | ALDH1A1 (0.51) | ALDH1A1HPGDTSHRPOLBCYP2C19 | |
| SCHEMBL28409396 | 0.70 | ALDH1A1 (0.47) | ALDH1A1HPGDTSHRCYP1A2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-28 | — | — | US | claimed |
| US-20130310269-A1 | HOT-START DIGITAL PCR | SO AUSTIN (US) | 2013-11-21 | — | — | US | disclosed |
| WO-2013166466-A1 | HOT-START DIGITAL PCR | BIO-RAD LABORATORIES, INC. (US) | 2013-11-07 | — | — | WO | disclosed |
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | POLL, POLRMT, POLN | ALDH1A1 1877/4885HPGD 2897/4885TSHR 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.